The product portfolio of this division includes leading biopharmaceuticals such as the cancer drug Erbitux® (marketed outside the U.S.) and the multiple sclerosis treatment Rebif®. In addition, we offer therapies to treat infertility, growth disorders, cardiovascular and metabolic diseases. Reseach and development activities focus on the core therapeutic areas of oncology, immuno-oncology, fertility, endocrinology and biosimilars.
Our enduring commitment and focus in specialist indications enable the division to deliver targeted medicines and innovative drug delivery systems to patients all over the world. We generate 60% of our sales with our four top-selling biopharmaceuticals. In medical biotechnology, we are the leader in Europe. In order to further expand this position, we are currently expanding Europe’s most modern biotechnology manufacturing facility, located in Switzerland.
Headquarter of EMD Serono in Rockland, MA